SCHEMBL26643108

SCHEMBL26643108

Cc1cnc(-n2cc(Cl)cn2)c(C(=O)O)c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOTUM Q6P988 4/20 0.37
ELANE P08246 1/20 0.37
HCRTR1 O43613 1/20 0.35
HSD17B10 Q99714 2/20 0.35
HPGD P15428 2/20 0.35
KDM4E B2RXH2 1/20 0.35
NPC1 O15118 1/20 0.35
LMNA P02545 1/20 0.35
TP53 P04637 1/20 0.35
RAB9A P51151 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
EGLN1 Q9GZT9 3/20 0.35
DHODH Q02127 1/20 0.35
MAPT P10636 1/20 0.34
HTT P42858 1/20 0.34
ADAMTS5 Q9UNA0 1/20 0.34
POLB P06746 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
MYC P01106 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26643160 0.87 KDM4E (0.37) HPGDKDM4ENPC1RAB9AEGLN1
SCHEMBL26643225 0.83 EGLN1 (0.38) NOTUMHSD17B10HPGDKDM4ENPC1
SCHEMBL26769898 0.79 NOS3 (0.37) ELANEHPGDKDM4ESMN1; SMN2MAPT
SCHEMBL15351384 0.77 EGLN1 (0.43) ELANEHSD17B10TP53EGLN1POLB
SCHEMBL26643068 0.77 LMNA (0.46) HCRTR1KDM4ELMNAEGLN1MAPT
SCHEMBL1672011 0.75 HCRTR1 (0.45) HCRTR1KDM4EMYCGABRPGABRD
SCHEMBL26643032 0.72 KDM4E (0.41) NOTUMHCRTR1KDM4ENPC1RAB9A
SCHEMBL1671789 0.72 HCRTR1 (0.49) NOTUMHCRTR1KDM4E
SCHEMBL15350037 0.71 ELANE (0.37) ELANEHSD17B10HPGDLMNASMN1; SMN2
SCHEMBL31430855 0.71 KDR (0.47) NOTUMHSD17B10HPGDKDM4ENPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023218023-A1 THIAZOLOARYL-METHYL SUBSTITUTED CYCLIC HYDRAZINE-N-CARBOXAMIDE DERIVATIVES IDORSIA PHARMACEUTICALS LTD (CH) 2023-11-16 WO disclosed